Sanofi SNY
NASDAQ SNY
$48.39 +0.02 (+0.04%)
At close: Nov 16, 2026 · 4:00 PM EST

Sanofi (SNY) Return on Capital Employed [ROCE] (2018 - 2026)

Updated

Sanofi (SNY) recorded Return on Capital Employed [ROCE] of 6.08% in Q2 2026, down 1.67 percentage points from 7.75% a year earlier.

Analysis

Sanofi (SNY) Return on Capital Employed [ROCE] (2018 - 2026) Analysis & Trends

For FY2024, Sanofi reported Return on Capital Employed [ROCE] of 7.22%, up 0.42 percentage points from FY2023.

  • Annual Return on Capital Employed [ROCE] has a five-year change of +3.72 percentage points (FY2019 to FY2024).
  • Across earlier years, Return on Capital Employed [ROCE] came in at 6.80% in FY2023 (-2.93 pp), 9.73% in FY2022 (+1.32 pp), 8.41% in FY2021 (-6.27 pp) and 14.68% in FY2020 (+11.19 pp).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 17.52%
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 21.60%
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 4.65%
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 9.91%
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 17.37%
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn -6.15%
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 11.32%
10 Sanofi 59.05 Bn 29.25 Bn 33.35 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.08%
Dec 31, 2025 6.05%
Jun 30, 2025 7.75%
Dec 31, 2018 12.40%
Sep 30, 2018 10.11%
Jun 30, 2018 4.36%
Mar 31, 2018 5.87%
API Access

Sanofi Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=SNY&period=max&api_key=YOUR_API_KEY